Txinno Bioscience
Txinno Bioscience was founded in 2020 and is headquartered in Yongin, South Korea.
- Headquarters
- Yongin
- Founded
- 2020
- Website
- eng.txinno.com
About
Txinno Bioscience is a South Korean clinical-stage biotech developing novel small molecule cancer therapies, including RAS pathway and innate immune-targeting drug candidates.
Summary
Txinno Bioscience is a Biotech company based in Yongin, South Korea, founded in 2020.
Similar Companies
Tiantan Biological / China Biologic (泰邦生物集团)
China's leading blood products manufacturer
Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired
Global contract research organization providing comprehensive drug development and laboratory ser...
Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/txinno-bioscience"><img src="https://indexed.vc/api/badge/company/txinno-bioscience" alt="Txinno Bioscience on Indexed.vc" width="260" height="76" /></a>